This study suggests that metabotropic cannabinoid receptors, including type 1 and type 2, are not associated with cell death during the early stages of ischemia, pointing to the potential utility of targeting TRPA1 for neuroprotective strategies in the context of retinal ischemia. The gene discussed is TRPA1; the disease is retinal ischemia.